Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPREO: High vs Low Dose Aspirin for Preeclampsia Prevention
NCT03961360Phase 3Completed
- Sponsor
- UTHealth Houston
- Start
- May 2019
- Primary completion
- Apr 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in preeclampsia, sponsored by UTHealth Houston. Started May 2019; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03961360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961360.